Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Convertible Debt (2024 - 2025)

Orthopediatrics has reported Convertible Debt over the past 2 years, most recently at $48.5 million for Q4 2025.

  • Quarterly results put Convertible Debt at $48.5 million for Q4 2025, up 1.2% from a year ago — trailing twelve months through Dec 2025 was $48.5 million (up 1.2% YoY), and the annual figure for FY2025 was $48.5 million, up 1.2%.
  • Convertible Debt for Q4 2025 was $48.5 million at Orthopediatrics, roughly flat from $48.3 million in the prior quarter.
  • Over the last five years, Convertible Debt for KIDS hit a ceiling of $48.5 million in Q4 2025 and a floor of $47.8 million in Q3 2024.